Cheaper Biosimilar Drugs Expand Access to Cancer Immunotherapy in India
Immunotherapy prescriptions for cancer patients in India are rising, driven by the availability of affordable biosimilar drugs. Doctors say cheaper versions of nivolumab have made the treatment more accessible to patients. Research suggests lower doses may work effectively for Indian patients, which further reduces the cost of therapy. Despite this progress, challenges around drug availability and hospital practices still persist.
This is an AI-generated summary. ShortSingh links to the original source for the complete article.



Discussion (0)
Log in to join the discussion and vote.
Log in